SEC14L2
Basic information
Region (hg38): 22:30396941-30425303
Previous symbols: [ "C22orf6" ]
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the SEC14L2 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 0 | |||||
missense | 13 | 14 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 1 | |||||
Total | 0 | 0 | 13 | 1 | 1 |
Variants in SEC14L2
This is a list of pathogenic ClinVar variants found in the SEC14L2 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
22-30397150-C-G | not specified | Uncertain significance (Dec 28, 2023) | ||
22-30399716-G-A | not specified | Uncertain significance (Apr 17, 2023) | ||
22-30406381-G-A | not specified | Uncertain significance (Dec 21, 2023) | ||
22-30407108-G-A | not specified | Uncertain significance (Dec 17, 2023) | ||
22-30407128-A-G | not specified | Uncertain significance (Jan 09, 2024) | ||
22-30407568-C-A | not specified | Uncertain significance (Jan 02, 2024) | ||
22-30407590-A-G | Benign (Jun 13, 2018) | |||
22-30409214-A-G | not specified | Uncertain significance (Apr 12, 2022) | ||
22-30409259-C-G | not specified | Uncertain significance (Dec 20, 2023) | ||
22-30409292-A-T | Likely benign (Aug 16, 2018) | |||
22-30409443-G-T | not specified | Uncertain significance (Jun 17, 2024) | ||
22-30409454-C-A | not specified | Uncertain significance (Aug 05, 2023) | ||
22-30409456-G-A | not specified | Uncertain significance (Dec 01, 2022) | ||
22-30415794-C-T | not specified | Uncertain significance (Apr 24, 2023) | ||
22-30415803-G-A | not specified | Uncertain significance (Feb 02, 2022) | ||
22-30415957-G-A | not specified | Uncertain significance (Sep 23, 2023) | ||
22-30416293-T-C | not specified | Uncertain significance (Apr 17, 2024) | ||
22-30422377-G-C | not specified | Uncertain significance (Jun 19, 2024) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
SEC14L2 | protein_coding | protein_coding | ENST00000312932 | 12 | 28460 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
2.92e-8 | 0.919 | 125699 | 0 | 49 | 125748 | 0.000195 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.989 | 187 | 229 | 0.816 | 0.0000123 | 2640 |
Missense in Polyphen | 87 | 118.04 | 0.73706 | 1327 | ||
Synonymous | -0.516 | 94 | 87.8 | 1.07 | 0.00000465 | 756 |
Loss of Function | 1.81 | 16 | 25.9 | 0.617 | 0.00000135 | 284 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000496 | 0.000496 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.000326 | 0.000326 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.000150 | 0.000149 |
Middle Eastern | 0.000326 | 0.000326 |
South Asian | 0.000327 | 0.000327 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Carrier protein. Binds to some hydrophobic molecules and promotes their transfer between the different cellular sites. Binds with high affinity to alpha-tocopherol. Also binds with a weaker affinity to other tocopherols and to tocotrienols. May have a transcriptional activatory activity via its association with alpha-tocopherol. Probably recognizes and binds some squalene structure, suggesting that it may regulate cholesterol biosynthesis by increasing the transfer of squalene to a metabolic active pool in the cell.;
- Pathway
- Validated transcriptional targets of deltaNp63 isoforms
(Consensus)
Recessive Scores
- pRec
- 0.126
Intolerance Scores
- loftool
- 0.552
- rvis_EVS
- 0.24
- rvis_percentile_EVS
- 69.21
Haploinsufficiency Scores
- pHI
- 0.280
- hipred
- N
- hipred_score
- 0.396
- ghis
- 0.486
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.223
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | High |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Sec14l2
- Phenotype
- homeostasis/metabolism phenotype;
Gene ontology
- Biological process
- regulation of cholesterol biosynthetic process;positive regulation of transcription, DNA-templated
- Cellular component
- nucleus;cytoplasm;cytosol;extracellular exosome
- Molecular function
- phospholipid binding;vitamin E binding